Letter campaign sought to pressure FDA action on stem cell clinics.
- Published in:
- Nature Medicine, 2014, v. 20, n. 8, p. 796, doi. 10.1038/nm0814-796
- By:
- Publication type:
- Article
Works matching DE "CENTER for Biologics Evaluation %26 Research (U.S.)"
Results: 17
1
2
Regulatory agency struggles under the weight of genomic data.
- Published in:
- Nature Medicine, 2013, v. 19, n. 4, p. 385, doi. 10.1038/nm0413-385
- By:
- Publication type:
- Article
3
A Versatile and Scalable Platform That Streamlines Data Collection for Patient-Centered Studies: Usability and Feasibility Study.
- Published in:
- JMIR Formative Research, 2022, v. 6, n. 9, p. 1, doi. 10.2196/38579
- By:
- Publication type:
- Article
4
Report of the Food and Drug Administration Subcommittee on Xenotransplantation: meeting of 3 and 4 June, 1999, Center for Biologics Evaluation and Research.
- Published in:
- Xenotransplantation, 1999, v. 6, n. 4, p. 232, doi. 10.1034/j.1399-3089.1999.00034.x
- Publication type:
- Article
5
A cost-effectiveness approach to the qualification and acceptance of biomarkers.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 897, doi. 10.1038/nrd2174
- By:
- Publication type:
- Article
6
US regulator wades into stem cell therapies for heart disease.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 496, doi. 10.1038/nbt0609-496c
- By:
- Publication type:
- Article
7
Missing Data Issues at the FDA Center for Biologics Evaluation and Research.
- Published in:
- Journal of Biopharmaceutical Statistics, 2011, v. 21, n. 2, p. 196, doi. 10.1080/10543406.2011.550095
- By:
- Publication type:
- Article
8
Clinical Efficacy of Cell Culture—Derived and Egg-Derived Inactivated Subunit Influenza Vaccines in Healthy Adults.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 9, p. 997, doi. 10.1086/656578
- By:
- Publication type:
- Article
9
Combination Products Regulation at the FDA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 468, doi. 10.1038/clpt.2009.28
- By:
- Publication type:
- Article
10
Public Health Service Recommendations for the Use of Vaccines manufactured With Bovine-Derived Materials.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 285, n. 5, p. 532, doi. 10.1001/jama.285.5.532
- Publication type:
- Article
11
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
- Published in:
- Vox Sanguinis, 2012, v. 102, n. 3, p. 204, doi. 10.1111/j.1423-0410.2011.01541.x
- By:
- Publication type:
- Article
12
'Wrong blood in tube': solutions for a persistent problem.
- Published in:
- Vox Sanguinis, 2011, v. 100, n. 3, p. 298, doi. 10.1111/j.1423-0410.2010.01391.x
- By:
- Publication type:
- Article
13
Knowledge of food and drug administration reportable deviations.
- Published in:
- Transfusion, 2011, v. 51, n. 7pt2, p. 1619, doi. 10.1111/j.1537-2995.2011.03223.x
- By:
- Publication type:
- Article
14
FDA Performance Goals for Approving Drugs and Biologics.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 2, p. 189, doi. 10.1001/jama.2009.974
- By:
- Publication type:
- Article
15
Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children.
- Published in:
- Journal of Infection in Developing Countries, 2014, v. 8, n. 9, p. 1160, doi. 10.3855/jidc.4594
- By:
- Publication type:
- Article
16
Additively manufactured medical products - the FDA perspective.
- Published in:
- 3D Printing in Medicine, 2016, v. 2, n. 1, p. 1, doi. 10.1186/s41205-016-0005-9
- By:
- Publication type:
- Article
17
From The Editor-In-Chief.
- Published in:
- BioProcessing Journal, 2017, v. 16, n. 1, p. 3
- By:
- Publication type:
- Article